Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1978 Mar;31(3):408–413.

Comparison of a leucocyte adherence test with the leucocyte migration inhibition test and skin reactivity to PPD.

A W Bullen, M S Losowsky
PMCID: PMC1541254  PMID: 350459

Abstract

Using PPD as antigen, a leucocyte adherence test was compared with the leucocyte migration inhibition test and with the results of skin testing in healthy subjects. In the presence of antigen, leucocyte adherence was significantly greater in skin test-positive subjects than in skin test-negative subjects who had not previously had BCG vaccination. When the test was performed in heterologous serum, skin test-negative subjects who had had previous BCG vaccination showed significantly greater leucocyte adherence in the presence of antigen than skin test-negative subjects who had not had BCG vaccination; this difference was not present in autologous serum and its abolition was attributed to a serum blocking effect. The leucocyte adherence test correlated with the results of the leucocyte migration inhibition test in heterologous serum, and also with the results of skin testing interpreted in the light of previous vaccination history. The finding of increased rather than decreased adherence in the presence of antigen, although previously reported, is unusual.

Full text

PDF
412

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitstead P. R., Gowland G. The leucocyte adherence inhibtion test in cancer of the large bowel. Br J Cancer. 1975 Nov;32(5):568–573. doi: 10.1038/bjc.1975.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bleifer D. J., Sheppard J. J., Karpman H. L., Bleifer S. B. Phenytoin after recovery from myocardial infarction. Lancet. 1972 Feb 26;1(7748):495–495. doi: 10.1016/s0140-6736(72)90159-6. [DOI] [PubMed] [Google Scholar]
  3. Clausen J. E., Soborg M. In vitro detection of tuberculin hypersensitivity in man. Specific migration inhibition of white blood cells from tuberculin-positive persons. Acta Med Scand. 1969 Sep;186(3):227–230. [PubMed] [Google Scholar]
  4. Cooperband S. R., Bondevik H., Schmid K., Mannick J. A. Transformation of human lymphocytes: inhibition by homologous alpha globulin. Science. 1968 Mar 15;159(3820):1243–1244. doi: 10.1126/science.159.3820.1243. [DOI] [PubMed] [Google Scholar]
  5. Halliday W. J., Halliday J. W., Campbell C. B., Maluish A. E., Powell L. W. Specific immunodiagnosis of hepatocellular carcinoma by leucocyte adherence inhibition. Br Med J. 1974 May 18;2(5915):349–352. doi: 10.1136/bmj.2.5915.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Halliday W. J., Maluish A., Isbister W. H. Detection of anti-tumour cell mediated immunity and serum blocking factors in cancer patients by the leucocyte adherence inhibition test. Br J Cancer. 1974 Jan;29(1):31–35. doi: 10.1038/bjc.1974.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Halliday W. J., Maluish A., Miller S. Blocking and unblocking of cell-mediated anti-tumor immunity in mice, as detected by the leucocyte adherence inhibition test. Cell Immunol. 1974 Mar 15;10(3):467–475. doi: 10.1016/0008-8749(74)90138-5. [DOI] [PubMed] [Google Scholar]
  8. Heilman D. H., McFarland W. Inhibition of tuberculin-induced mitogenesis in cultures of lymphocytes from tuberculous donors. Int Arch Allergy Appl Immunol. 1966;30(1):58–66. doi: 10.1159/000229793. [DOI] [PubMed] [Google Scholar]
  9. Holt P. G., Roberts L. M., Fimmel P. J., Keast D. The L.A.I. microtest: a rapid and sensitive precedure for the demonstration of cell-mediated immunity in vitro. J Immunol Methods. 1975 Sep;8(3):277–288. doi: 10.1016/0022-1759(75)90122-2. [DOI] [PubMed] [Google Scholar]
  10. Jensen B., Kurpisz M., Rubin B. Antigen specific lymphocyte activity in vitro by peripheral blood leucocytes from Mantoux positive and negative human beings. I. Comparison of quantitative and qualitative differences in the PPD-specific lymphoproliferative response of lymphocytes from the two kinds of donors. Clin Exp Immunol. 1977 Feb;27(2):303–312. [PMC free article] [PubMed] [Google Scholar]
  11. Lampert F., Dietmair E. A leukocyte adherence inhibition test for cell-mediated immunity. Klin Wochenschr. 1973 Feb 15;51(4):198–199. doi: 10.1007/BF01468343. [DOI] [PubMed] [Google Scholar]
  12. Levene G. M., Turk J. L., Wright D. J., Grimble A. G. Reduced lymphocyte transformation due to a plasma factor in patients with active syphilis. Lancet. 1969 Aug 2;2(7614):246–247. doi: 10.1016/s0140-6736(69)90010-5. [DOI] [PubMed] [Google Scholar]
  13. Maluish A., Halliday W. J. Cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test. J Natl Cancer Inst. 1974 May;52(5):1415–1420. doi: 10.1093/jnci/52.5.1415. [DOI] [PubMed] [Google Scholar]
  14. Matsaniotis N., Tsenghi C., Economou-Mavrou C., Metaxotou-Stavridaki C. Skin hypersensitivity and in vitro lymphocytic reactivity to tuberculin in childhood. J Pediatr. 1968 May;72(5):599–605. doi: 10.1016/s0022-3476(68)80001-0. [DOI] [PubMed] [Google Scholar]
  15. Newberry W. M., Jr, Chandler J. W., Jr, Chin T. D., Kirkpatrick C. H. Immunology of the mycoses. I. Depressed lymphocyte transformation in chronic histoplasmosis. J Immunol. 1968 Feb;100(2):436–443. [PubMed] [Google Scholar]
  16. Passaleva A., Forti A., Ricci M. Inhibition of leucocyte migration in man by the agarose plate technique using protein purified derivatives (PPD) from three different sources. Acta Allergol. 1974 Jun;29(3):209–221. doi: 10.1111/j.1398-9995.1974.tb01649.x. [DOI] [PubMed] [Google Scholar]
  17. Silobrcić V., Sabioncello A., Mazuran R., Dekaris D., Kadrnka-Lovrencić M. A comparison of the inhibition of leucocyte migration and monocyte spreading as in vitro assays for tuberculin hypersensitivity in man. Clin Exp Immunol. 1975 May;20(2):239–247. [PMC free article] [PubMed] [Google Scholar]
  18. Thomas J. W., Clements D., Grzybowski S. In vitro lymphocyte responses and skin test reactivity following BCG vaccination. Clin Exp Immunol. 1971 Nov;9(5):611–623. [PMC free article] [PubMed] [Google Scholar]
  19. Walters B. A., Chick J. E., Halliday W. J. Cell-mediated immunity and serum blocking factors in patients with chronic dermatophytic infections. Int Arch Allergy Appl Immunol. 1974;46(6):849–857. doi: 10.1159/000231187. [DOI] [PubMed] [Google Scholar]
  20. Weisbart R. H., Bluestone R., Goldberg L. S., Pearson C. M. Migration enhancement factor: a new lymphokine. Proc Natl Acad Sci U S A. 1974 Mar;71(3):875–879. doi: 10.1073/pnas.71.3.875. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES